David M Bryant

Has grant

University Name
Country flag
United Kingdom

Research Interests

Explore related searches

Contact this professor

LinkedIn
ORCID
Google Scholar
Academic Page

Recent Grants

Grant: Close

OrgTIP: A transplantable organoid-to-in vivo pipeline for targeting phospholipid metabolism to stop colorectal carcinoma

Open Date: 2021-02-01

Close Date: 2025-01-31

Grant: Close

ARF GTPase regulation of prostate tumorigenesis: spheroid and in vivo approaches

Open Date: 2012-09-08

Close Date: 2014-08-31

Grant: Close

Role of caveolin-1 and breast cancer mutants in epithelial transformation.

Open Date: 2007-01-01

Close Date:

Articles (10)

<scp>PTEN</scp> deficiency exposes a requirement for an <scp>ARF GTPase</scp> module for integrin‐dependent invasion in ovarian cancer

Dysregulation of the PI3K/AKT pathway is a common occurrence in high‐grade serous ovarian carcinoma (HGSOC), with the loss of the tumour suppressor PTEN in HGSOC being associated with poor prognosis. The cellular mechanisms of how PTEN loss contributes to HGSOC are largely unknown. We here utilise time‐lapse imaging of HGSOC spheroids coupled to a machine learning approach to classify the phenotype of PTEN loss. PTEN deficiency induces PI(3,4,5)P 3 ‐rich and ‐dependent membrane protrusions into the extracellular matrix (ECM), resulting in a collective invasion phenotype. We identify the small GTPase ARF6 as a crucial vulnerability of HGSOC cells upon PTEN loss. Through a functional proteomic CRISPR screen of ARF6 interactors, we identify the ARF GTPase‐activating protein (GAP) AGAP1 and the ECM receptor β1‐integrin (ITGB1) as key ARF6 interactors in HGSOC regulating PTEN loss‐associated invasion. ARF6 functions to promote invasion by controlling the recycling of internalised, active β1‐integrin to maintain invasive activity into the ECM. The expression of the CYTH2‐ARF6‐AGAP1 complex in HGSOC patients is inversely associated with outcome, allowing the identification of patient groups with improved versus poor outcome. ARF6 may represent a therapeutic vulnerability in PTEN‐depleted HGSOC.

Year:

2023

Collaborators (8)

Shehab Ismail

Associate Professor

KU Leuven

BELGIUM

Danny Huang

Professor of Cancer Structural Biology

University of Glasgow

UNITED KINGDOM

Mohammed Mansour

Lecturer in Biomedical Science

London South Bank University

UNITED KINGDOM

Robert Bristow

The University of Manchester

UNITED KINGDOM

Jennifer Morton

Professor

University of Glasgow

UNITED KINGDOM

Martin Kampmann

University of Zurich

SWITZERLAND

Fernanda Kugeratski

The University of Texas MD Anderson Cancer Center

UNITED STATES

Izzy Jayasinghe

University of Sheffield

UNITED KINGDOM
Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI